Beranda › Gangguan Metabolik › California
Uji klinis Gangguan Metabolik di California
12 studi untuk Gangguan Metabolik mencari peserta di lokasi di California.
Kota di California
- Los Angeles4 studi
- Fresno3 studi
- Sacramento3 studi
- Mountain View3 studi
- Simi Valley3 studi
- Escondido3 studi
Teks studi resmi (Bahasa Inggris)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
- University of California - San Francisco, San Francisco
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06525636A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Glendale
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07723833A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- 89bio Clinical Study Site, Escondido
- dan 13 lainnya
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Camarillo
- 89bio Clinical Study Site, Canoga Park
- 89bio Clinical Study Site, Coronado
- dan 10 lainnya
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06419374Blood Specimen Collection For Laboratory Assay Research
- Roman Health Ventures Study Site, San Francisco
Menerima pesertaStudi observasionalMenyebutkan pembayaran untuk peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06046651Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- VA Greater Los Angeles Healthcare System, North Hills
Menerima pesertaSukarelawan sehat diterima
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT05516277A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
- Ronald Reagan UCLA Medical Center, Los Angeles
- University of Stanford Medical Center, Palo Alto
Menerima pesertaFase 1/2
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT05130437Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
- University of California, Davis; Department of Nutrition, Davis
Menerima pesertaSukarelawan sehat diterima
Usia 55 hingga 70 · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT05236374Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- UCSD Altman Clinical and Transalational Research Institute Building, Los Angeles
- Ronald Reagan UCLA Medical Center, Los Angeles
- Lucile Packard Children's Hospital Stanford, Stanford
Menerima pesertaFase 1/2
Semua usia · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT04159103Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Limb Preservation Platform Inc, Fresno
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
- dan 1 lainnya
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2025 · NCT06681428A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism
- Citruslabs, Santa Monica
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 13 Des 2024 · NCT06700915Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.